Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish … K Teppo, GYH Lip, KEJ Airaksinen, O Halminen, J Haukka, J Putaala, ... The Lancet Regional Health–Europe, 2024 | 5 | 2024 |
Effect of air pollution exposure on risk of acute coronary syndromes in Poland: a nationwide population-based study (EP-PARTICLES study) Ł Kuźma, EJ Dąbrowski, A Kurasz, M Święczkowski, P Jemielita, ... The Lancet Regional Health–Europe 41, 2024 | 4 | 2024 |
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications K Teppo, KEJ Airaksinen, J Jaakkola, O Halminen, B Salmela, E Kouki, ... European Heart Journal 45 (20), 1819-1827, 2024 | 4 | 2024 |
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial GYH Lip, J Nikorowitsch, S Sehner, N Becher, E Bertaglia, ... European Heart Journal 45 (19), 1733-1737, 2024 | 2 | 2024 |
2024 Chinese expert consensus guidelines on the diagnosis and treatment of Atrial Fibrillation in the Elderly. Executive Summary Y Wang, Y Guo, M Qin, J Fan, M Tang, X Zhang, H Wang, X Li, GYH Lip Thrombosis and Haemostasis, 2024 | 6 | 2024 |
RE: Optimising stroke prevention in patients with atrial fibrillation DA Lane, A Wolff, E Shantsila, GYH Lip | 4 | 2024 |
Antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19: an American College of Chest Physicians Expert Panel Report T Potpara, DJ Angiolillo, B Bikdeli, D Capodanno, O Cole, AC Yataco, ... Chest 164 (6), 1531-1550, 2023 | 8 | 2023 |
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international … DA Gorog, JL Ferreiro, I Ahrens, J Ako, T Geisler, S Halvorsen, K Huber, ... Nature Reviews Cardiology 20 (12), 830-844, 2023 | 20 | 2023 |
Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study F Frost, D Nazareth, L Fauchier, D Wat, J Shelley, P Austin, MJ Walshaw, ... European Respiratory Journal 62 (4), 2023 | 10 | 2023 |
Anticoagulation with edoxaban in patients with atrial high-rate episodes P Kirchhof, T Toennis, A Goette, AJ Camm, HC Diener, N Becher, ... New England Journal of Medicine 389 (13), 1167-1179, 2023 | 162 | 2023 |
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial SG Goodman, PG Steg, Y Poulouin, DL Bhatt, VA Bittner, R Diaz, G Garon, ... Journal of the American Heart Association 12 (18), e029216, 2023 | 10 | 2023 |
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial P Kanagaratnam, DP Francis, D Chamie, C Coyle, A Marynina, G Katritsis, ... Journal of Thrombosis and Haemostasis 21 (8), 2213-2222, 2023 | 1 | 2023 |
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference RB Schnabel, EA Marinelli, E Arbelo, G Boriani, S Boveda, CM Buckley, ... Europace 25 (1), 6-27, 2023 | 108 | 2023 |
Psychological interventions for depression in adolescent and adult congenital heart disease DG Leo, U Islam, RR Lotto, A Lotto, DA Lane Cochrane database of systematic reviews, 2023 | 92* | 2023 |
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom P Burdett, GYH Lip European Heart Journal-Quality of Care and Clinical Outcomes 8 (8), 892-898, 2022 | 13 | 2022 |
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with … DA Gorog, YX Gue, TF Chao, L Fauchier, JL Ferreiro, K Huber, ... Europace 24 (11), 1844-1871, 2022 | 27 | 2022 |
Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association GN Levine, JW McEvoy, JC Fang, C Ibeh, CP McCarthy, A Misra, ZI Shah, ... Circulation 146 (15), e205-e223, 2022 | 116 | 2022 |
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 2685 | 2022 |
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper DA Gorog, YX Gue, TF Chao, L Fauchier, JL Ferreiro, K Huber, ... Thrombosis and Haemostasis 122 (10), 1625-1652, 2022 | 58 | 2022 |
Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients: A Nationwide Propensity Score–Weighted Study D Kim, PS Yang, SC You, E Jang, HT Yu, TH Kim, HN Pak, MH Lee, ... Annals of Internal Medicine 175 (10), 1356-1365, 2022 | 12 | 2022 |